Full Name | tiopronin |
Drug | Tiopronin |
Manufacturer | Generic |
Route of Administration | Oral |
Site of Care | Home |
Approved Indication | In combination with high fluid intake, alkali, and diet modification, for the prevention of cystine stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone |
Disease | Homozygous Cystinuria |
Therapeutic Area | Nephrology |
Enrollment Form Link | Tiopronin Enrollment Form |
Phone Number | 800-764-0147 |
Fax Number | 877-848-6579 |
Product Website |
About Homozygous Cystinuria
Homozygous cystinuria is a rare genetic disorder characterized by the presence of two identical mutations in the genes responsible for cystine transport in the kidneys. This results in impaired reabsorption of cystine, leading to its excessive accumulation in the urine. Cystine forms crystals that can combine to create kidney stones, causing recurrent and often painful episodes of nephrolithiasis. Individuals with homozygous cystinuria face an increased risk of kidney damage and related complications.